Johnson & Johnson vaccine less effective against Delta variant: study

A recent study from researchers at NYU’s Grossman School of Medicines found that the Johnson & Johnson vaccine may be less effective in battling COVID-19 variants than vaccines made by Pfizer-BioNTech or Moderna.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.